Infectious Diseases Clinical Trials Network (IDCTN)
Federal opportunity from Public Agency. Place of performance: United States.
- Source
- Open on official portal →
- Solicitation
- 07MfpMwNIZLmdtk9eYl5
- Performance
- United States
- Response
- No due date posted
Point of Contact
Agency & Office
Applicable wage determinations
Best public WD match for the notice location and scope.
Description
The National Institute of Allergy and Infectious Diseases (NIAID) is seeking to establish a cooperative network to rapidly implement clinical trials for therapeutics, vaccines, biologics, diagnostics, and devices targeting infectious diseases. The network will consist of Clinical Trial Evaluation Units (CTEUs) and a Network Coordination Center (NCC). The initiative aims to support the evaluation of innovative concepts for advancing public health while mentoring the next generation of clinical... | Title: Infectious Diseases Clinical Trials Network (IDCTN), Agency: U.S. National Institutes of Health, State: United States of America, Open Date: 11/18/2025, Close Date: 6/10/2026, Last Updated Date: 4/7/2026
Pricing and bid posture
Contractor-side estimate from visible notice metadata, NAICS/PSC, contract type, schedule hints, and BidPulsar workpaper assumptions. Not an IGCE, incumbent price, award value, or government budget.
This advisory bid range is visible page text for contractors and search engines: it summarizes the modeled floor, target, and premium bid posture for this solicitation.
Market snapshot
Baseline awarded-market signal across all contracting (sample of 400 recent awards; refreshed periodically).
Files
Files size/type shown when available.
BidPulsar Analysis
A practical, capture-style breakdown of fit, requirements, risks, and next steps.
The National Institute of Allergy and Infectious Diseases (NIAID) is initiating the Infectious Diseases Clinical Trials Network (IDCTN) to facilitate rapid implementation of clinical trials for various therapeutics and diagnostics targeting infectious diseases. This project requires the formation of Clinical Trial Evaluation Units (CTEUs) and a Network Coordination Center (NCC), with the solicitation number 07MFPMWNIZLMDTK9EYL5 indicating a structured bidding process. With a performance period spanning from November 18, 2025, to June 10, 2026, this opportunity seeks to mentor the next generation in clinical research while advancing public health initiatives.
NIAID aims to establish a cooperative network for rapid clinical trials focused on infectious diseases, which includes evaluation units and coordination centers to streamline the process and mentor upcoming clinical researchers.
- Organizations with experience in clinical trials for infectious diseases
- Firms with capabilities in coordinating clinical research networks
- Teams with expertise in developing therapeutics and diagnostics
- Establish Clinical Trial Evaluation Units (CTEUs)
- Set up a Network Coordination Center (NCC)
- Conduct evaluation of therapeutics, vaccines, and diagnostics
- Mentor next-generation clinical researchers
- Implement rapid clinical trial protocols
- Identifying relevant clinical trial experience
- Proposed organizational structure for CTEUs and NCC
- Detailed timeline aligning with performance period
- Technical approach for trial implementation
- Team qualifications including resumes and past performance
More BidPulsar strategy notesCompliance, pricing, teaming, risks, questions, and coverage notes
- Confirm alignment with NIAID's research objectives
- Adhere to federal regulations for clinical trials
- Verify compliance with ethical standards in research
- Consider competitive pricing based on industry standards
- Include cost breakdown for CTEUs and NCC operations
- Factor in potential funding for mentoring programs
- Potential partnerships with academic institutions for mentorship
- Collaboration with firms specializing in clinical trial logistics
- Subcontracting research organizations with infectious disease expertise
- Complexities in coordinating multiple CTEUs and NCC
- Potential delays in regulatory approvals
- Risk of funding cuts during the performance period
- What specific outcomes are expected from the clinical trials?
- How will success be measured for the network components?
- What resources are available for mentoring and training?
Some notices publish limited source detail. Confirm these points before final bid/no-bid decisions.
- Detailed information about specific diseases targeted
- Exact requirements for CTEUs and NCC
- Clarification on available funding and budgets
- Specific evaluation criteria for proposals
- Details on how mentoring will be structured
- Information about the selection process
- Performance metrics expected from the network
- Requirements for reporting and accountability
Service match
Optional support routes matched to this notice after the core solicitation details.
Related hubs & trends
Navigate the lattice: hubs for browsing, trends for pricing signals.